Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial ...
Further strengthens Centrient Pharmaceuticals’ position as the global business-to-business industry leader in beta-lactam antibiotics Broadens Centrient Pharmaceuticals’ product portfolio with sterile ...
One suspicious item FDA investigators found during their inspection of Centrient’s manufacturing facility? A document shredder the company had labeled "emergency ...
This agreement represents a strategic step in innovation for Centrient. It will catalyse the expansion and diversification of their product portfolio while driving the development of sustainable and ...
RIJSWIJK, Netherlands and BOSTON, May 25, 2023 /PRNewswire/ -- Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and ...
The US Food and Drug Administration (FDA) last recently warned Centrient Pharmaceuticals for current good manufacturing practice (CGMP) violations at its active pharmaceutical ingredient (API) ...
ROTTERDAM, The Netherlands, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Centrient Pharmaceuticals, the global leader in the production and commercialisation of sustainable antibiotics, next-generation statins ...
New Delhi : Netherland based Centrient Pharmaceuticals has announced that its the first company to publicly announce 100 per cent Predicted No Effect Concentration (PNEC) compliance for its entire ...
RIJSWIJK, Netherlands & BARCELONA, Spain--(BUSINESS WIRE)--Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermatology, today announced an agreement with Centrient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results